NCT04030689

Brief Summary

The program " Au labo sans ordo " aims to increase HIV testing coverage, in order to improve the first stage of the HIV care cascade in Paris and the Alpes-Maritimes, areas facing a much higher HIV epidemic than the other regions in metropolitan France. Both departments are engaged in the Fast Track Cities Initiative.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 19, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 24, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

July 8, 2020

Status Verified

July 1, 2019

Enrollment Period

1 year

First QC Date

July 19, 2019

Last Update Submit

July 7, 2020

Conditions

HIV SeropositivityHIV Testing

Keywords

HIV TestingCombined HIV preventionLinkage to careImplementation planCost-effectiveness

Outcome Measures

Primary Outcomes (1)

  • Positive VihTest

    Number of patients enrolled in the study with demographics, risk factors, clinical therapeutic and biological characteristics

    548 days

Study Arms (1)

Axis 2

Each patient diagnosed HIV positive following VihTest test will be invited to participate to ALSO-Parcours; This program aimed to decribe the link to care for this population and to make a descriptive analysis of this HIV+ patients.

Other: data collected from patient file

Interventions

data collected from patient fileOTHER

socio-demographics, previous HIV testing history, history of HIV contamination, clinics HIV related data will be collected for each patient who notified his non-objection to participate to this non interventional study.

Axis 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Axis 2 Major patient diagnosed HIV positive after a VihTest in a Private Laboratory in Paris or in the Alpes Maritimes.

You may qualify if:

  • Major
  • being diagnosed HIV positive after a VihTest

You may not qualify if:

  • Minor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital l'Archet Service Infectiologie

Nice, 06200, France

RECRUITING

MeSH Terms

Conditions

HIV Seropositivity

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Pascal PUGLIESE, MD

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vanina OLIVERI

CONTACT

492034254oliveri.v@chu-nice.fr

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2019

First Posted

July 24, 2019

Study Start

July 1, 2019

Primary Completion

June 30, 2020

Study Completion

March 31, 2021

Last Updated

July 8, 2020

Record last verified: 2019-07

Locations

FR(1)